MOEDYRAB-L

RABEPRAZOLE

The fastest acting PPI thus provides fast relief from symptoms potent PPI provides 99% inhibition of proton pump thus maximum suppression of and release is achieved. maintains mean acid output for a significantly greater mean percentage of time when compared to pantoprazole (91.9% Vs 78.9%)

LEVOSULPIRIDE

The new prokinetic agent, demonstrates greater central atidopaminergic activity, antiemetic & anti dyspeptic effects. Provides better relief from overall symptoms thus ensures better quality of life to patients. Well tolerated by patients with high safety profile.increases lower esophageal sphincter pressure, quickens gastric emptying and offers gastrokinetic effect with gastrokinetic effect also improves glycemic control in diabetic gastroparesis